Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising adoption of rapid coronavirus test kits, fastrack approval of coronavirus diagnostic kits, and government initiatives to boost sales of coronavirus test kits.
The test kits market in North America is segmented as below:
By End-user
- Government
- Non-government
By Type
- Rapid test kit
- RT-PCR
- Others
The report on the test kits market in North America covers the following areas:
- Test kits market in North America sizing
- Test kits market in North America forecast
- Test kits market in North America industry analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The research team recognises the following companies as the key players in the test kits market in North America: Abbott Laboratories, Advaite Inc., Becton Dickinson and Co., Biomedomics Inc., bioMerieux SA, Cellex Inc., Co Diagnostics Inc., Cue Health Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Laboratory Corp. of America Holdings, Mammoth Biosciences Inc., MyBioSource Inc., QIAGEN NV, Quidelortho Corp., RayBiotech Life Inc., Robert Bosch GmbH, SHERLOCK BIOSCIENCES, Talis Biomedical Corp., and Thermo Fisher Scientific Inc..One of the report's analysts commented on the report, saying: 'The latest trend gaining momentum in the market is launch of new COVID-19 test kits.'
According to the report, one of the major drivers for this market is the rising adoption of rapid coronavirus test kits.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Advaite Inc.
- Becton Dickinson and Co.
- Biomedomics Inc.
- bioMerieux SA
- Cellex Inc.
- Co Diagnostics Inc.
- Cue Health Inc.
- Danaher Corp.
- DiaSorin SpA
- F. Hoffmann La Roche Ltd.
- Hologic Inc.
- Laboratory Corp. of America Holdings
- Mammoth Biosciences Inc.
- MyBioSource Inc.
- QIAGEN NV
- Quidelortho Corp.
- RayBiotech Life Inc.
- Robert Bosch GmbH
- SHERLOCK BIOSCIENCES
- Talis Biomedical Corp.
- Thermo Fisher Scientific Inc.